Overview

Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the safety profile of bevacizumab in combination with chemotherapy for the treatment of metastatic colorectal cancer
Details
Lead Sponsor:
Sun Yat-sen University
Collaborator:
Proswell Medical Corporation
Treatments:
Bevacizumab